TG Therapeutics presented BRIUMVI® data at the CMSC annual meeting, highlighting its use in relapsing multiple sclerosis patients.

RRMS is the most common form of multiple sclerosis (MS) and is characterized by episodes of new or worsening signs or symptoms (relapses) followed by periods of recovery.

Both borderline personality disorder and bipolar spectrum disorders can present with intense affective shifts, but in borderline patients, these shifts are reactive to interpersonal events rather ...

Discover why BTK inhibitors have attracted interest for treating multiple sclerosis, as a few late-stage candidates close in on FDA approval.

Two prominent scientists who study multiple sclerosis — Dr. Alberto Ascherio and Dr. Stephen Hauser — are co-winners of a 2025 Breakthrough Prize in Life Sciences.

While genetics play a role in the risk of developing multiple sclerosis, environmental factors such as diet, infectious disease and gut health are major contributors.

Researchers from Bonn and Erlangen identify the protein MLC1 as a target antigen in multiple sclerosis (MS); a chronic inflammatory disease of the central nervous system caused by the immune ...

Background Emerging evidence indicates that diet, including fish consumption, may play a role in the development and progression of multiple sclerosis (MS). We aimed to investigate the influence of ...

Learn about the 4 main types of MS, their causes, and management strategies. Understand how each type uniquely affects individuals for tailored treatment.

In a study of commonly used treatments for multiple sclerosis, both medical and behavioral interventions, and a combination of the two, resulted in significant improvements in fatigue. Researchers ...

Takeaways Late-onset multiple sclerosis is a form of the disease in which symptoms develop after age 50. Common symptoms include trouble with balance and walking, plus thinking and memory problems.